Wilson Sonsini Goodrich & Rosati advised Forte Biosciences on the deal. Forte Biosciences, a clinical-stage biopharmaceutical company, announced the pricing of an underwritten public offering of…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now